Joslin Diabetes Center Launches Veraxa Health Inc. To Meet Large Unmet Patient Need For Timely Detection Of Diabetic Eye Disease
11/15/2006 10:46:24 AM
BOSTON--(BUSINESS WIRE)--Joslin Diabetes Center, global leader in diabetes research, care and education, announced today the launch of Veraxa Health, Inc. as an independent company. The first for-profit spin-off in the center’s 100-plus year history, Veraxa will market the Joslin Vision NetworkTM (JVN), a proven retinal imaging device and clinical service developed by Joslin to address a significant patient need: detection and management of diabetic retinopathy and other ocular disorders. JVN is delivered via custom Joslin software and nonmydriatic cameras supplied by Topcon Medical Systems of Paramus, N.J., which also provided bridge funding to help accelerate Veraxa Health’s growth in the market.
>>> Discuss This Story
comments powered by